Search

Your search keyword '"Vesuna, Farhad"' showing total 204 results

Search Constraints

Start Over You searched for: Author "Vesuna, Farhad" Remove constraint Author: "Vesuna, Farhad"
204 results on '"Vesuna, Farhad"'

Search Results

4. The Transcription Factor Encyclopedia

5. Supplementary Figures 1 - 11 from The Twist Box Domain Is Required for Twist1-induced Prostate Cancer Metastasis

6. Data from The Twist Box Domain Is Required for Twist1-induced Prostate Cancer Metastasis

7. Supplementary Table 2 from The Twist Box Domain Is Required for Twist1-induced Prostate Cancer Metastasis

8. Supplementary Table 1 from The Twist Box Domain Is Required for Twist1-induced Prostate Cancer Metastasis

18. Supplementary Figure 2 from Twist Overexpression Induces In vivo Angiogenesis and Correlates with Chromosomal Instability in Breast Cancer

19. Supplementary Figure 1 from Twist Overexpression Induces In vivo Angiogenesis and Correlates with Chromosomal Instability in Breast Cancer

20. Supplementary Figure Legends from Twist Overexpression Induces In vivo Angiogenesis and Correlates with Chromosomal Instability in Breast Cancer

21. Data from Twist Overexpression Induces In vivo Angiogenesis and Correlates with Chromosomal Instability in Breast Cancer

25. RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2

27. Targeting DDX3 with a small molecule inhibitor for lung cancer therapy

31. Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33

32. Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33

36. Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach

37. Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach

41. Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach

44. Role of DDX3 in the pathogenesis of inflammatory bowel disease

45. Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer

47. Role of DDX3 in the pathogenesis of inflammatory bowel disease

48. Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer

49. Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer

50. Organ-specific isogenic metastatic breast cancer cell lines exhibit distinct Raman spectral signatures and metabolomes

Catalog

Books, media, physical & digital resources